Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jgr.2020.12.005 http://scihub22266oqcxt.onion/10.1016/j.jgr.2020.12.005 33623472!7891076!33623472     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Ginseng+Res 2021 ; 45 (4): 535-537 Nephropedia Template TP {{tp|p=33623472|t=2021. Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza |pdf=|usr=}}{{33623472}} gab.com Text Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza JO: J Ginseng Res http://www.kidney.de/pget.php?&tw=1&pmid=33623472 #FOAvip In the 1918 influenza pandemic, more than 95% of mortalities were ascribed to bacterial pneumonia. After the primary influenza infection, the innate immune system is attenuated, and the susceptibility to bacteria is increased. Subsequent bacterial pneumonia exacerbates morbidity and increases the mortality rate. Similarly, COVID-19 infection attenuates innate immunity and results in pneumonia. In addition, the current pneumococcal conjugate vaccine may have limited defense against secondary pneumococcal infection after influenza infection. Therefore, until a fully protective vaccine is available, a method of increasing immunity may be helpful. Ginseng has been shown to increase the defense against influenza in clinical trials and animal experiments, as well as the defense against pneumococcal pneumonia in animal experiments. Based on these findings, ginseng is suspected to be helpful for providing immunity against COVID-19. Twit Text FOAVip Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza ????J Ginseng Res http://www.kidney.de/pget.php?&tw=1&pmid=33623472 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33623472 #FOAvip English Wikipedia <ref>{{Cite pmid|33623472}}</ref> Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza #MMPMID33623472 Lee WS; Rhee DK J Ginseng Res 2021[Jul]; 45 (4): 535-537 PMID33623472show ga In the 1918 influenza pandemic, more than 95% of mortalities were ascribed to bacterial pneumonia. After the primary influenza infection, the innate immune system is attenuated, and the susceptibility to bacteria is increased. Subsequent bacterial pneumonia exacerbates morbidity and increases the mortality rate. Similarly, COVID-19 infection attenuates innate immunity and results in pneumonia. In addition, the current pneumococcal conjugate vaccine may have limited defense against secondary pneumococcal infection after influenza infection. Therefore, until a fully protective vaccine is available, a method of increasing immunity may be helpful. Ginseng has been shown to increase the defense against influenza in clinical trials and animal experiments, as well as the defense against pneumococcal pneumonia in animal experiments. Based on these findings, ginseng is suspected to be helpful for providing immunity against COVID-19. äCorona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COV(epmc).pdf DeepDyve Pubget Overpricing